Immunic presents data from phase 2 emphasis trial of vidofludimus calcium in relapsing-remitting multiple sclerosis at msmilan2023: the 9th joint ectrims-actrims meeting
– improvement in serum neurofilament light chain (nfl) observed in both treatment arms of vidofludimus calcium over placebo – – nfl effect consistent with recently released data from separate, phase 2 calliper trial of vidofludimus calcium in progressive multiple sclerosis – new york , oct. 11, 2023 /prnewswire/ -- immunic, inc. (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced that robert j. fox, m.d., staff neurologist, mellen center for multiple sclerosis, vice-chair for research, neurological institute, cleveland clinic, cleveland, ohio, today presented data from the company's phase 2 emphasis trial of nuclear receptor related 1 (nurr1) activator, vidofludimus calcium (imu-838), in relapsing-remitting multiple sclerosis (rrms) at msmilan2023: the 9th joint ectrims-actrims meeting, taking place october 11-13 in milan, italy.
IMUX Ratings Summary
IMUX Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission